Influence of Ovarian Hormones on Skeletal Muscle Contractility

Chapter
First Online:

Abstract

There is a loss of skeletal muscle strength around the time of menopause in women, probably due to the decline of ovarian hormone production. The maintenance of muscle strength and contractility with age and with loss of ovarian hormones are critical issues because the risk for disability and dependent living increases with muscle weakness. There is substantial evidence that estradiol is beneficial to muscle strength. Thus, better understanding of the mechanisms by which estradiol affects contractility and how the loss of this hormone is detrimental to skeletal muscle function is critical. This chapter focuses on ovarian hormones, specifically how the lack of estradiol affects skeletal muscle contractility in both postmenopausal women and rodent models.

Keywords

Aging Estradiol Estrogen Hormone replacement therapy Muscle force Myosin Postmenopausal Power Ovariectomy Strength 
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Armstrong AL, Oborne J et al (1996) Effects of hormone replacement therapy on muscle performance and balance in post-menopausal women. Clin Sci (Lond) 91(6):685–690Google Scholar
  2. 2.
    Asmussen E (1980) Aging and exercise. In: Horvath S (ed) Environmental physiology. Elsevier North Holland Inc, New York, pp 419–428Google Scholar
  3. 3.
    Asmussen E, Heebollnielsen K (1962) Isometric muscle strength in relation to Age in Men and women. Ergonomics 5(1–4):167–169CrossRefGoogle Scholar
  4. 4.
    Bassey EJ, Mockett SP et al (1996) Lack of variation in muscle strength with menstrual status in healthy women aged 45–54 years: data from a national survey. Eur J Appl Physiol Occup Physiol 73(3–4):382–386PubMedCrossRefGoogle Scholar
  5. 5.
    Carville SF, Rutherford OM et al (2006) Power output, isometric strength and steadiness in the leg muscles of pre- and postmenopausal women; the effects of hormone replacement therapy. Eur J Appl Physiol 96(3):292–298PubMedCrossRefGoogle Scholar
  6. 6.
    Dieli-Conwright CM, Spektor TM et al (2009) Influence of hormone replacement therapy on eccentric exercise induced myogenic gene expression in postmenopausal women. J Appl Physiol 107(5):1381–1388PubMedCrossRefGoogle Scholar
  7. 7.
    Eason JM, Schwartz GA et al (2000) Sexually dimorphic expression of myosin heavy chains in the adult mouse masseter. J Appl Physiol 89(1):251–258PubMedGoogle Scholar
  8. 8.
    Finni T, Noorkoiv M et al (2011) Muscle function in monozygotic female twin pairs discordant for hormone replacement therapy. Muscle Nerve 44(5):769–775PubMedCrossRefGoogle Scholar
  9. 9.
    Fisher JS, Hasser EM et al (1998) Effects of ovariectomy and hindlimb unloading on skeletal muscle. J Appl Physiol 85(4):1316–1321PubMedGoogle Scholar
  10. 10.
    Fonseca H, Powers SK et al (2012) Physical inactivity is a major contributor to ovariectomy-induced sarcopenia. Int J Sports Med 33(4):268–278PubMedCrossRefGoogle Scholar
  11. 11.
    Greeves JP, Cable NT et al (1999) Changes in muscle strength in women following the menopause: a longitudinal assessment of the efficacy of hormone replacement therapy. Clin Sci (Lond) 97(1):79–84CrossRefGoogle Scholar
  12. 12.
    Greising SM, Baltgalvis KA et al (2009) Hormone therapy and skeletal muscle strength: a meta-analysis. J Gerontol A Biol Sci Med Sci 64(10):1071–1081PubMedCrossRefGoogle Scholar
  13. 13.
    Greising SM, Baltgalvis KA et al (2011a) Estradiol's beneficial effect on murine muscle function is independent of muscle activity. J Appl Physiol 110(1):109–115PubMedCrossRefGoogle Scholar
  14. 14.
    Greising SM, Carey RS et al (2011b) Estradiol treatment, physical activity, and muscle function in ovarian-senescent mice. Exp Gerontol 46(8):685–693PubMedGoogle Scholar
  15. 15.
    Heikkinen J, Kyllonen E et al (1997) HRT and exercise: effects on bone density, muscle strength and lipid metabolism. A placebo controlled 2-year prospective trial on two estrogen-progestin regimens in healthy postmenopausal women. Maturitas 26(2):139–149PubMedCrossRefGoogle Scholar
  16. 16.
    Hubal MJ, Ingalls CP et al (2005) Effects of eccentric exercise training on cortical bone and muscle strength in the estrogen-deficient mouse. J Appl Physiol 98(5):1674–1681PubMedCrossRefGoogle Scholar
  17. 17.
    Kadi F, Karlsson C et al (2002) The effects of physical activity and estrogen treatment on rat fast and slow skeletal muscles following ovariectomy. J Muscle Res Cell Motil 23(4):335–339PubMedCrossRefGoogle Scholar
  18. 18.
    Kallman DA, Plato CC et al (1990) The role of muscle loss in the age-related decline of grip strength: cross-sectional and longitudinal perspectives. J Gerontol 45(3):M82–M88PubMedCrossRefGoogle Scholar
  19. 19.
    Kobori M, Yamamuro T (1989) Effects of gonadectomy and estrogen administration on rat skeletal muscle. Clin Orthop 243:306–311PubMedGoogle Scholar
  20. 20.
    Lee CE, McArdle A et al (2007) The role of hormones, cytokines and heat shock proteins during age-related muscle loss. Clin Nutr 26(5):524–534PubMedCrossRefGoogle Scholar
  21. 21.
    Lemoine S, Granier P et al (2003) Estrogen receptor alpha mRNA in human skeletal muscles. Med Sci Sports Exerc 35(3):439–443PubMedCrossRefGoogle Scholar
  22. 22.
    Liu YH, Jia SS et al (2009) Effects of ovariectomy on rat genioglossal muscle contractile properties and fiber-type distribution. Angle Orthod 79(3):509–514PubMedGoogle Scholar
  23. 23.
    Maddalozzo GF, Cardinal BJ et al (2004) The association between hormone therapy use and changes in strength and body composition in early postmenopausal women. Menopause 11(4):438–446PubMedCrossRefGoogle Scholar
  24. 24.
    Maltin CA, Delday MI et al (1989) Fiber-type composition of nine rat muscles. I. Changes during the first year of life. Am J Physiol 257(6 Pt 1):E823–E827PubMedGoogle Scholar
  25. 25.
    McClung JM, Davis JM et al (2006) Estrogen status and skeletal muscle recovery from disuse atrophy. J Appl Physiol 100(6):2012–2023PubMedCrossRefGoogle Scholar
  26. 26.
    McCormick KM, Burns KL et al (2004) Effects of ovariectomy and estrogen on skeletal muscle function in growing rats. J Muscle Res Cell Motil 25:21–27PubMedCrossRefGoogle Scholar
  27. 27.
    Meeuwsen IB, Samson MM et al (2000) Evaluation of the applicability of HRT as a preservative of muscle strength in women. Maturitas 36(1):49–61PubMedCrossRefGoogle Scholar
  28. 28.
    Messier V, Rabasa-Lhoret R et al (2011) Menopause and sarcopenia: A potential role for sex hormones. Maturitas 68(4):331–336PubMedCrossRefGoogle Scholar
  29. 29.
    Moran AL, Warren GL et al (2006) Removal of ovarian hormones from mature mice detrimentally affects muscle contractile function and myosin structural distribution. J Appl Physiol 100(2):548–559PubMedCrossRefGoogle Scholar
  30. 30.
    Moran AL, Nelson SA et al (2007) Estradiol replacement reverses ovariectomy-induced muscle contractile and myosin dysfunction in mature female mice. J Appl Physiol 102(4):1387–1393PubMedCrossRefGoogle Scholar
  31. 31.
    Narici MV, Bordini M et al (1991) Effect of aging on human adductor pollicis muscle function. J Appl Physiol 71(4):1277–1281PubMedGoogle Scholar
  32. 32.
    Nelson JF, Felicio LS et al (1982) A longitudinal study of estrous cyclicity in aging C57BL/6J mice: I. Cycle frequency, length and vaginal cytology. Biol Reprod 27(2):327–339PubMedCrossRefGoogle Scholar
  33. 33.
    Onambele GN, Bruce SA et al (2006) Oestrogen status in relation to the early training responses in human thumb adductor muscles. Acta Physiol (Oxf) 188(1):41–52CrossRefGoogle Scholar
  34. 34.
    Pette D, Staron RS (1990) Cellular and molecular diversities of mammalian skeletal muscle fibers. Rev Physiol Biochem Pharmacol 116:1–76PubMedGoogle Scholar
  35. 35.
    Phillips SK, Rook KM et al (1993) Muscle weakness in women occurs at an earlier age than in men, but strength is preserved by hormone replacement therapy. Clin Sci (Lond) 84(1):95–98Google Scholar
  36. 36.
    Piccone CM, Brazeau GA et al (2005) Effect of oestrogen on myofibre size and myosin expression in growing rats. Exp Physiol 90(1):87–93PubMedCrossRefGoogle Scholar
  37. 37.
    Pollanen E, Sipila S et al (2011) Differential influence of peripheral and systemic sex steroids on skeletal muscle quality in pre- and postmenopausal women. Aging Cell 10(4):650–660PubMedCrossRefGoogle Scholar
  38. 38.
    Ribom EL, Piehl-Aulin K et al (2002) Six months of hormone replacement therapy does not influence muscle strength in postmenopausal women. Maturitas 42(3):225–231PubMedCrossRefGoogle Scholar
  39. 39.
    Rogers NH, Perfield JW 2nd et al (2010) Loss of ovarian function in mice results in abrogated skeletal muscle PPARdelta and FoxO1-mediated gene expression. Biochem Biophys Res Commun 392(1):1–3PubMedCrossRefGoogle Scholar
  40. 40.
    Ronkainen PH, Kovanen V et al (2009) Postmenopausal hormone replacement therapy modifies skeletal muscle composition and function: a study with monozygotic twin pairs. J Appl Physiol 107(1):25–33PubMedCrossRefGoogle Scholar
  41. 41.
    Samson MM, Meeuwsen IB et al (2000) Relationships between physical performance measures, age, height and body weight in healthy adults. Age Ageing 29(3):235–242PubMedCrossRefGoogle Scholar
  42. 42.
    Schneider BS, Fine JP et al (2004) The effects of estradiol and progesterone on plantarflexor muscle fatigue in ovariectomized mice. Biol Res Nurs 5(4):265–275PubMedCrossRefGoogle Scholar
  43. 43.
    Schoenberg M, Wells JB (1984) Stiffness, force, and sarcomere shortening during a twitch in frog semitendinosus muscle bundles. Biophys J 45(2):389–397PubMedCrossRefGoogle Scholar
  44. 44.
    Sipila S, Poutamo J (2003) Muscle performance, sex hormones and training in peri-menopausal and post-menopausal women. Scand J Med Sci Sports 13(1):19–25PubMedCrossRefGoogle Scholar
  45. 45.
    Sipila S, Taaffe DR et al (2001) Effects of hormone replacement therapy and high-impact physical exercise on skeletal muscle in post-menopausal women: a randomized placebo-controlled study. Clin Sci (Lond) 101(2):147–157CrossRefGoogle Scholar
  46. 46.
    Sitnick M, Foley AM et al (2006) Ovariectomy prevents the recovery of atrophied gastrocnemius skeletal muscle mass. J Appl Physiol 100(1):286–293PubMedCrossRefGoogle Scholar
  47. 47.
    Skelton DA, Phillips SK et al (1999) Hormone replacement therapy increases isometric muscle strength of adductor pollicis in post-menopausal women. Clin Sci (Lond) 96(4):357–364CrossRefGoogle Scholar
  48. 48.
    Suzuki S, Yamamuro T (1985) Long-term effects of estrogen on rat skeletal muscle. Exp Neurol 87(2):291–299PubMedCrossRefGoogle Scholar
  49. 49.
    Taaffe DR, Sipila S et al (2005) The effect of hormone replacement therapy and/or exercise on skeletal muscle attenuation in postmenopausal women: a yearlong intervention. Clin Physiol Funct Imaging 25(5):297–304PubMedCrossRefGoogle Scholar
  50. 50.
    Taylor JA, Kandarian SC (1994) Advantage of normalizing force production to myofibrillar protein in skeletal muscle cross-sectional area. J Appl Physiol 76(2):974–978PubMedCrossRefGoogle Scholar
  51. 51.
    Velders M, Solzbacher M et al (2010) Estradiol and genistein antagonize the ovariectomy effects on skeletal muscle myosin heavy chain expression via ER-beta mediated pathways. J Steroid Biochem Mol Biol 120(1):53–59PubMedCrossRefGoogle Scholar
  52. 52.
    Warren GL, Lowe DA et al (1996) Estradiol effect on anterior crural muscles-tibial bone relationship and susceptibility to injury. J Appl Physiol 80(5):1660–1665PubMedGoogle Scholar
  53. 53.
    Wattanapermpool J, Reiser PJ (1999) Differential effects of ovariectomy on calcium activation of cardiac and soleus myofilaments. Am J Physiol 277(2 Pt 2):H467–H473PubMedGoogle Scholar
  54. 54.
    Widrick JJ, Maddalozzo GF et al (2003) Morphological and functional characteristics of skeletal muscle fibers from hormone-replaced and nonreplaced postmenopausal women. J Gerontol A Biol Sci Med Sci 58(1):3–10PubMedCrossRefGoogle Scholar
  55. 55.
    Wiik A, Glenmark B et al (2003) Oestrogen receptor beta is expressed in adult human skeletal muscle both at the mRNA and protein level. Acta Physiol Scand 179(4):381–387PubMedCrossRefGoogle Scholar
  56. 56.
    Wiik A, Ekman M et al (2009) Expression of both oestrogen receptor alpha and beta in human skeletal muscle tissue. Histochem Cell Biol 131(2):181–189PubMedCrossRefGoogle Scholar
  57. 57.
    Wohlers LM, Sweeney SM et al (2009) Changes in contraction-induced phosphorylation of AMP-activated protein kinase and mitogen-activated protein kinases in skeletal muscle after ovariectomy. J Cell Biochem 107(1):171–178PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Program in Physical Therapy and Rehabilitation ScienceUniversity of MinnesotaMinneapolisUSA
  2. 2.Department of Physiology & Biomedical EngineeringMayo ClinicRochesterUSA

Personalised recommendations